258 related articles for article (PubMed ID: 12702051)
21. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice.
Davidson NJ; Hudak SA; Lesley RE; Menon S; Leach MW; Rennick DM
J Immunol; 1998 Sep; 161(6):3143-9. PubMed ID: 9743382
[TBL] [Abstract][Full Text] [Related]
22. CD4+ T cells from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rodents migrate to the recipient's colon upon transfer; down-regulation by CD8+ T cells.
Palmen MJ; Wijburg OL; Kunst IH; Kroes H; van Rees EP
Clin Exp Immunol; 1998 May; 112(2):216-25. PubMed ID: 9649183
[TBL] [Abstract][Full Text] [Related]
23. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
[TBL] [Abstract][Full Text] [Related]
24. Predominant T helper type 2-inflammatory responses promote murine colon cancers.
Osawa E; Nakajima A; Fujisawa T; Kawamura YI; Toyama-Sorimachi N; Nakagama H; Dohi T
Int J Cancer; 2006 May; 118(9):2232-6. PubMed ID: 16331625
[TBL] [Abstract][Full Text] [Related]
25. Preventive effects of Schistosoma japonicum ova on trinitrobenzenesulfonic acid-induced colitis and bacterial translocation in mice.
Zhao Y; Zhang S; Jiang L; Jiang J; Liu H
J Gastroenterol Hepatol; 2009 Nov; 24(11):1775-80. PubMed ID: 20136961
[TBL] [Abstract][Full Text] [Related]
26. Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation.
Kitani A; Fuss IJ; Nakamura K; Schwartz OM; Usui T; Strober W
J Exp Med; 2000 Jul; 192(1):41-52. PubMed ID: 10880525
[TBL] [Abstract][Full Text] [Related]
27. Dendritic cells treated by Trichinella spiralis muscle larval excretory/secretory products alleviate TNBS-induced colitis in mice.
Jin X; Yang Y; Bai X; Shi H; Zhang W; Zhang Z; Jia W; Lin J; Liu M; Liu X
Int Immunopharmacol; 2019 May; 70():378-386. PubMed ID: 30852293
[TBL] [Abstract][Full Text] [Related]
28. Effect of recombinant serine protease from adult stage of Trichinella spiralis on TNBS-induced experimental colitis in mice.
Pang J; Ding J; Zhang L; Zhang Y; Yang Y; Bai X; Liu X; Jin X; Guo H; Yang Y; Liu M
Int Immunopharmacol; 2020 Sep; 86():106699. PubMed ID: 32570037
[TBL] [Abstract][Full Text] [Related]
29. Effect of Trichinella spiralis intervention on TNBS-induced experimental colitis in mice.
Xu J; Yu P; Wu L; Liu M; Lu Y
Immunobiology; 2019 Jan; 224(1):147-153. PubMed ID: 30413272
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice.
Gurtner GJ; Newberry RD; Schloemann SR; McDonald KG; Stenson WF
Gastroenterology; 2003 Dec; 125(6):1762-73. PubMed ID: 14724829
[TBL] [Abstract][Full Text] [Related]
31. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.
Gay J; Kokkotou E; O'Brien M; Pothoulakis C; Karalis KP
Neuroimmunomodulation; 2006; 13(2):114-21. PubMed ID: 17077645
[TBL] [Abstract][Full Text] [Related]
33. Exosomes derived from interleukin-10-treated dendritic cells can inhibit trinitrobenzene sulfonic acid-induced rat colitis.
Yang X; Meng S; Jiang H; Chen T; Wu W
Scand J Gastroenterol; 2010 Oct; 45(10):1168-77. PubMed ID: 20469967
[TBL] [Abstract][Full Text] [Related]
34. Bifidobacterium infantis attenuates colitis by regulating T cell subset responses.
Zuo L; Yuan KT; Yu L; Meng QH; Chung PC; Yang DH
World J Gastroenterol; 2014 Dec; 20(48):18316-29. PubMed ID: 25561798
[TBL] [Abstract][Full Text] [Related]
35. NK 1.1+ T cell: a two-faced lymphocyte in immune modulation of the IL-4/IFN-gamma paradigm.
Trop S; Ilan Y
J Clin Immunol; 2002 Sep; 22(5):270-80. PubMed ID: 12405160
[TBL] [Abstract][Full Text] [Related]
36. Interferon gamma stabilizes the T helper cell type 1 phenotype.
Zhang Y; Apilado R; Coleman J; Ben-Sasson S; Tsang S; Hu-Li J; Paul WE; Huang H
J Exp Med; 2001 Jul; 194(2):165-72. PubMed ID: 11457891
[TBL] [Abstract][Full Text] [Related]
37. Cytokine expression and the role of Thl7 cells in mice colitis.
He Y; Lin LJ; Zheng CQ; Jin Y; Lin Y
Hepatogastroenterology; 2012 Sep; 59(118):1809-13. PubMed ID: 23115792
[TBL] [Abstract][Full Text] [Related]
38. Pattern of cytokine and adhesion molecule mRNA in hapten-induced relapsing colon inflammation in the rat.
Sun FF; Lai PS; Yue G; Yin K; Nagele RG; Tong DM; Krzesicki RF; Chin JE; Wong PY
Inflammation; 2001 Feb; 25(1):33-45. PubMed ID: 11293664
[TBL] [Abstract][Full Text] [Related]
39. All-trans retinoic acid ameliorates trinitrobenzene sulfonic acid-induced colitis by shifting Th1 to Th2 profile.
Bai A; Lu N; Zeng H; Li Z; Zhou X; Chen J; Liu P; Peng Z; Guo Y
J Interferon Cytokine Res; 2010 Jun; 30(6):399-406. PubMed ID: 20187766
[TBL] [Abstract][Full Text] [Related]
40. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.
Takedatsu H; Michelsen KS; Wei B; Landers CJ; Thomas LS; Dhall D; Braun J; Targan SR
Gastroenterology; 2008 Aug; 135(2):552-67. PubMed ID: 18598698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
